Survey and Research Archives | Page 54 of 142 | Be Korea-savvy

Archive by category Survey and Research

Groundbreaking AI Satellite Project by GOTS and Marple Revolutionises Organic Cotton Detection

Groundbreaking AI Satellite Project by GOTS and Marple Revolutionises Organic Cotton Detection

97% accuracy rate in detecting cotton fields, over 80% accuracy in determining organic status Stuttgart, Germany, Sept. 17, 2024 (Korea Bizwire) – In a pioneering move that could reshape sustainable agriculture, the Global Organic Textile Standard (GOTS) and AI firm Marple have unveiled the results of their revolutionary Satellite Cotton Monitoring Project in India, demonstrating [...]

Boehringer’s nerandomilast meets primary endpoint in pivotal phase-III FIBRONEER™-IPF study

Boehringer’s nerandomilast meets primary endpoint in pivotal phase-III FIBRONEER™-IPF study

Topline data from FIBRONEER™-IPF show that the investigational compound nerandomilast met its primary endpoint, which was the absolute change from baseline in Forced Vital Capacity [mL] at week 52 versus placebo.  The FIBRONEER™-IPF trial is the largest trial in idiopathic pulmonary fibrosis (IPF) conducted to date. Patients were recruited in over 330 sites and in [...]

Avance Clinical Joins the Australian Clinical Trials Roadshow, Sharing Cost and Time Benefits for Early-Phase US Biotechs

Avance Clinical Joins the Australian Clinical Trials Roadshow, Sharing Cost and Time Benefits for Early-Phase US Biotechs

WAKE FOREST, N.C. and ADELAIDE, Australia, Sept. 13, 2024 (Korea Bizwire) – Avance Clinical, the market-leading CRO for biotechs, announced today that Avance Clinical will represent the CRO sector at the Australian Clinical Trials Roadshow (September 17-20) to share the unparalleled time, cost and quality opportunities for early phase US biotechs. Register Here Key Avance Clinical Australia [...]

Vaping Expected to Increase COPD Health and Economic Burden by 2050

Vaping Expected to Increase COPD Health and Economic Burden by 2050

New ResMed-supported research presented at ERS 2024 projects future Chronic Obstructive Pulmonary Disease (COPD) burden in Western Europe, accounting for increased air pollution, tobacco smoking, and vaping, with Non-Invasive Ventilation (NIV) enhancing survival rates. 88.7 million new COPD hospitalizations projected across Western Europe between 2019 – 2050 Vaping projected to incur almost €30 billion additional [...]

A new report from the Access to Medicine Foundation reveals how patient-focused pharma companies’ access efforts are

A new report from the Access to Medicine Foundation reveals how patient-focused pharma companies’ access efforts are

AMSTERDAM, Sept. 10, 2024 (Korea Bizwire) – The latest report from the Access to Medicine Foundation takes a first-ever look at the critical issue of how some of the largest pharmaceutical companies are reaching patients worldwide, especially in low- and middle-income countries (LMICs). Ahead of the 2024 Access to Medicine Index, the Foundation examined the [...]

Regulated Online Casinos using Military-Grade Technology to Outsmart Cyber Criminals

Regulated Online Casinos using Military-Grade Technology to Outsmart Cyber Criminals

WATERFORD, Ireland, Sept. 10, 2024 (Korea Bizwire) – With cybercrime running rampant and data breaches on the rise, trusted online casinos globally are arming themselves with the latest military-grade encryption technologies to outsmart even the most sophisticated cyber thugs. Minimum Deposit Casinos (MDC) – a leading global casino resource portal – said data breaches were becoming [...]

Boehringer’s zongertinib shows encouraging efficacy and tolerability profile in previously treated HER2 mutated lung cancer patients

Boehringer’s zongertinib shows encouraging efficacy and tolerability profile in previously treated HER2 mutated lung cancer patients

Beamion LUNG-1, Phase Ib met its primary endpoint, demonstrating a meaningful objective response rate (ORR) of 66.7%, as assessed by blinded independent central review (BICR)1 Preliminary activity in patients with brain metastases were also observed, with an intracranial response of 33% and 74% disease control rate (DCR)  Zongertinib was generally well tolerated, with mostly mild [...]

World First: TMC and PAMCO Achieve Breakthrough in Commercial-Scale Processing of Polymetallic Nodules, Successfully Producing Calcine

World First: TMC and PAMCO Achieve Breakthrough in Commercial-Scale Processing of Polymetallic Nodules, Successfully Producing Calcine

TMC and PAMCO successfully produced calcine from a 2,000-tonne sample of nodules collected during TMC subsidiary Nauru Ocean Resources Inc.’s 2022 test mining, at PAMCO’s Hachinohe Rotary Kiln Electric-Arc Furnace (RKEF) facility in Japan The nodules were heated to remove moisture and initiate the mineral transition to metallic form, producing approximately 500 tonnes of calcine in [...]

Bedford Metals Provides Corporate Update on Uranium Exploration Progress

Bedford Metals Provides Corporate Update on Uranium Exploration Progress

VANCOUVER, British Columbia, Sept. 06, 2024 (Korea Bizwire) – Bedford Metals Corp. (TSX-V: BFM, FWB: O8D, ISIN: CA0762301012) (the “Company” or “Bedford”) wishes to provide a corporate update. Bedford continues to focus on advancing its uranium exploration projects in the Athabasca region of northern Saskatchewan, Canada and has made meaningful progress with its exploration initiatives. As reported in previous [...]

Boehringer Ingelheim announces plans to advance potential new treatment for Geographic Atrophy, following positive Phase I results

Boehringer Ingelheim announces plans to advance potential new treatment for Geographic Atrophy, following positive Phase I results

Ingelheim, Germany and Basel, Switzerland, September 5, 2024 – Boehringer Ingelheim and CDR-Life today announce positive results from the Phase I evaluation of BI 771716 (Study Record | ClinicalTrials.gov), an investigational antibody fragment developed to preserve vision in people living with geographic atrophy (GA). BI 771716 met its primary safety endpoint following intravitreal administration of single and multiple [...]